ARYA Sciences Acquisition IV Corp (ARYD) Financials
$5.20
As on 22-Aug-2024 09:30EDT
Market cap
$50 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.7
Div. Yield
0 %
Cashflow ($ Mln) |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-0.73
|
-0.49
|
-1.07
|
0.00
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
--
|
-149.50
|
-149.50
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
-113.02
|
0.08
|
0.15
|
151.07
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
-0.41
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-2.50
|
2.23
|
-9.43
|
--
|
--
|
|||||
|
ROE (%)
|
-10.08
|
-2.53
|
2.23
|
-9.43
|
--
|
--
|
|||||
|
ROA (%)
|
-2.43
|
-2.22
|
2.08
|
-8.72
|
--
|
--
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
-551.61
|
--
|
151.41
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
-755.57
|
-132.12
|
69.17
|
-24,422.69
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
76.99
|
-167.85
|
147.91
|
-48,366.45
|
--
|
--
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
1.74
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-106.52
|
8.08
|
-0.01
|
0.08
|
--
|
--
|
|||||
|
Close Price ($)
|
11.23
|
10.90
|
10.10
|
9.92
|
--
|
--
|
|||||
|
High Price ($)
|
11.27
|
10.95
|
10.10
|
12.38
|
--
|
--
|
|||||
|
Low Price ($)
|
--
|
--
|
9.70
|
9.73
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
50.04
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.08
|
0.00
|
--
|
-0.83
|
--
|
|||||
|
Short term debt to equity ratio
|
0.14
|
0.08
|
0.00
|
--
|
-0.83
|
--
|
|||||
|
Current Ratio
|
0.01
|
0.01
|
0.02
|
0.15
|
0.03
|
--
|
|||||
|
Quick Ratio
|
0.01
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
-1.25
|
--
|
-1.97
|
-253.76
|
--
|
--
|
Operating Efficiency Ratios |
TTM | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|